{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:28:07Z","timestamp":1794119287166,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.psychres.2022.114857","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T13:01:17Z","timestamp":1663765277000},"page":"114857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review &amp; meta-analysis"],"prefix":"10.1016","volume":"317","author":[{"given":"Shakila","family":"Meshkat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazen","family":"Alnefeesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Youshay","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"D Di Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"B Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Ceban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanna","family":"MW Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2022.114857_bib0001","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2015.06.033","article-title":"Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT","volume":"186","author":"Allen","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2022.114857_bib0002","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial","volume":"10","author":"Almeida","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.psychres.2022.114857_bib0003","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0004","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jagp.2019.10.012","article-title":"An evaluation of the clinical and economic burden among older adult medicare-covered beneficiaries with treatment-resistant depression","volume":"28","author":"Benson","year":"2020","journal-title":"Am. J. Geriatri. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brainresbull.2014.04.005","article-title":"Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression","volume":"104","author":"Bilgen","year":"2014","journal-title":"Brain Res. Bull."},{"issue":"8","key":"10.1016\/j.psychres.2022.114857_bib0006","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euroneuro.2006.04.010","article-title":"Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients","volume":"16","author":"Bocchio-Chiavetto","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0007","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/15622975.2014.958101","article-title":"BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis","volume":"16","author":"Brunoni","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2022.114857_bib0008","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib81","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2022.114857_bib0009","article-title":"Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial","author":"Caliman-Fontes","year":"2021","journal-title":"Trends Psychiatry Psychother."},{"issue":"4","key":"10.1016\/j.psychres.2022.114857_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/ANA.0000000000000511","article-title":"Ketamine anesthesia does not improve depression scores in electroconvulsive therapy: a randomized clinical trial","volume":"30","author":"Carspecken","year":"2018","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"10.1016\/j.psychres.2022.114857_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castr\u00e9n","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.psychres.2022.114857_bib0012","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0013","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0014","first-page":"54","article-title":"Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment","volume":"46","author":"Deuschle","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145712000545","article-title":"Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder","volume":"16","author":"Duncan","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneumeth.2009.12.017","article-title":"Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions","volume":"187","author":"Elfving","year":"2010","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2009.02.032","article-title":"Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients","volume":"453","author":"Fernandes","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0018","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3164\/jcbn.19-55","article-title":"Induction of brain-derived neurotrophic factor in enteric glial cells stimulated by interleukin-1\u03b2 via a c-Jun N-terminal kinase pathway","volume":"66","author":"Fukumoto","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"10","key":"10.1016\/j.psychres.2022.114857_bib0019","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Galv\u00e3o-Coelho","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114857_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fpsyt.2012.00012","article-title":"Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression","volume":"3","author":"Gedge","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110229","article-title":"BDNF and pro-BDNF in serum and exosomes in major depression: evolution after antidepressant treatment","volume":"109","author":"Gelle","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2022.114857_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical Role of Brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res. Rev."},{"issue":"02","key":"10.1016\/j.psychres.2022.114857_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-1004594","article-title":"Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment","volume":"41","author":"Hellweg","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0025","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 8: assessing risk of bias in a randomized trial | Cochrane Training","author":"Higgins","year":"2020"},{"key":"10.1016\/j.psychres.2022.114857_bib0026","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/NDT.S248190","article-title":"BDNF and the antidepressant effects of ketamine and propofol in electroconvulsive therapy: a preliminary study","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"4","key":"10.1016\/j.psychres.2022.114857_bib0027","doi-asserted-by":"crossref","first-page":"e1079","DOI":"10.1038\/tp.2017.43","article-title":"The serum protein levels of the tPA\u2013BDNF pathway are implicated in depression and antidepressant treatment","volume":"7","author":"Jiang","year":"2017","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0028","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000484665","article-title":"Both serum brain-derived neurotrophic factor and interleukin-6 levels are not associated with therapeutic response to lamotrigine augmentation therapy in treatment-resistant depressive Disorder","volume":"75","author":"Kagawa","year":"2017","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00213-006-0399-y","article-title":"Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation","volume":"187","author":"Lang","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2022.114857_bib0030","first-page":"1","article-title":"Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids","author":"Leblhuber","year":"2021","journal-title":"J. Neural Transm."},{"issue":"42","key":"10.1016\/j.psychres.2022.114857_bib0031","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2019.34.e287","article-title":"Neurofeedback treatment on depressive symptoms and functional recovery in treatment-resistant patients with major depressive disorder: an open-label pilot study","volume":"34","author":"Lee","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.psychres.2022.114857_bib0032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12991-019-0248-0","article-title":"All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population","volume":"18","author":"Li","year":"2019","journal-title":"Ann Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0033","first-page":"1","article-title":"\"Prevalence of depression in the community from 30 countries between 1994 and 2014\"","volume":"8","author":"Lim Grace","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0034","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000352013","article-title":"Electroconvulsive therapy improves clinical manifestation with plasma BDNF levels unchanged in treatment-resistant depression patients","volume":"68","author":"Lin","year":"2013","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.psychres.2022.114857_bib0035","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)65221-2","article-title":"Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions","volume":"155","author":"Lommatzsch","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.psychres.2022.114857_bib0036","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrn1726","article-title":"The yin and yang of neurotrophin action","volume":"6","author":"Lu","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09537104.2020.1732322","article-title":"Platelet phenotype and function in the absence of splenic sequestration (Review)","volume":"32","author":"Luu","year":"2021","journal-title":"Platelets"},{"issue":"12","key":"10.1016\/j.psychres.2022.114857_bib0038","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0039","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/YCT.0000000000000583","article-title":"BDNF genotype and baseline serum levels in relation to electroconvulsive therapy effectiveness in treatment-resistant depressed patients","volume":"35","author":"Maffioletti","year":"2019","journal-title":"J. ECT"},{"key":"10.1016\/j.psychres.2022.114857_bib0040","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4088\/JCP.v68n0404","article-title":"Increased plasma con- centration of brain-derived neurotrophic factor with electroconvulsive therapy:a pilot study in patients with major depression","volume":"68","author":"Marano","year":"2007","journal-title":"J. Clin.Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0041","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","article-title":"Changes BDNF serum levels inpatients with depression disorder (MDD)after 6 months treatment with sertraline, escitalopram,or venlafaxine","volume":"43","author":"Matrisciano","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114857_bib0042","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trsl.2007.10.004","article-title":"Selective serotonin reuptake inhibitors: measurement of effect on platelet function","volume":"151","author":"McCloskey","year":"2008","journal-title":"Transl. Res."},{"issue":"5","key":"10.1016\/j.psychres.2022.114857_bib0043","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"19","key":"10.1016\/j.psychres.2022.114857_bib0044","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.3390\/ijms221910235","article-title":"Enteric microbiota-mediated serotonergic signaling in pathogenesis of irritable bowel syndrome","volume":"22","author":"Mishima","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.psychres.2022.114857_bib0045","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mp.2013.105","article-title":"Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N= 9484)","volume":"19","author":"Molendijk","year":"2014","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114857_bib0046","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study","volume":"32","author":"Okamoto","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0047","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0048","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jad.2013.03.015","article-title":"Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression","volume":"150","author":"Palm","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"5695","key":"10.1016\/j.psychres.2022.114857_bib0049","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1100135","article-title":"Cleavage of proBDNF by tPA\/plasmin is essential for long-term hippocampal plasticity","volume":"306","author":"Pang","year":"2004","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.psychres.2022.114857_bib0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.euroneuro.2009.01.002","article-title":"Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy","volume":"19","author":"Piccinni","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2022.114857_bib0051","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/srep17989","article-title":"A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.psychres.2022.114857_bib0052","article-title":"BDNF as a bio- marker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","author":"Polyakova","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2022.114857_bib0053","unstructured":"Quintana, D., & Tiebel, J. (2018). How to calculate statistical power for your meta-analysis. 10.17605\/OSF.IO\/5C7UZ."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(95)01321-0","article-title":"Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay","volume":"709","author":"Radka","year":"1996","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/15622975.2014.952775","article-title":"Brain-derived neurotrophic factor and subcallosal deep brain stimulation for refractory depression","volume":"16","author":"Ramasubbu","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0056","first-page":"1","article-title":"Unfolding the role of BDNF as a biomarker for treatment of depression","author":"Rana","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2022.114857_bib0057","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.psychres.2015.04.009","article-title":"Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels","volume":"227","author":"Rapinesi","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114857_bib0058","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0059","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.2271","article-title":"Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?","volume":"28","author":"Rybakowski","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114857_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpsychires.2014.06.018","article-title":"Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder","volume":"57","author":"Salehi","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2022.114857_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.12.018","article-title":"The International Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment","volume":"61","author":"Saveanu","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0062","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","article-title":"Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?","volume":"6","author":"Serra-Mill\u00e0s","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0063","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","author":"Sforzini","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0064","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3102\/1076998609346961","article-title":"How many studies do you need?: A primer on statistical power for meta-analysis","volume":"35","author":"Valentine","year":"2010","journal-title":"J. Educ. Behav. Stat."},{"issue":"11","key":"10.1016\/j.psychres.2022.114857_bib0065","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1111\/ejn.15232","article-title":"Brain stimulation effects on serum BDNF, VEGF, and TNF\u03b1 in treatment-resistant psychiatric disorders","volume":"53","author":"Valiuliene","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.psychres.2022.114857_bib0066","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.brs.2019.02.015","article-title":"Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression","volume":"12","author":"Vanicek","year":"2019","journal-title":"Brain Stimul."},{"issue":"5","key":"10.1016\/j.psychres.2022.114857_bib0067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127629","article-title":"The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study","volume":"10","author":"Vinberg","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2022.114857_bib0068","first-page":"7","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014","journal-title":"Ottawa Health Res. Institute Web Site"},{"key":"10.1016\/j.psychres.2022.114857_bib0069","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jad.2018.08.075","article-title":"Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression","volume":"241","author":"Wilkinson","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01887-1","article-title":"BDNF reverses aging-related microglial activation","volume":"17","author":"Wu","year":"2020","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.psychres.2022.114857_bib0071","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2020.05.010","article-title":"Increased ratio of mature BDNF to precursor-BDNF in patients with major depressive disorder with severe anhedonia","volume":"126","author":"Wu","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2022.114857_bib0072","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front Cell Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0073","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pnpbp.2009.12.003","article-title":"Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression","volume":"34","author":"Yoshimura","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114857_bib0074","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hup.1257","article-title":"Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients","volume":"27","author":"Yoshimura","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114857_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.680765","article-title":"Serum mBDNF and ProBDNF expression levels as diagnosis clue for early stage Parkinson's disease","volume":"12","author":"Yi","year":"2021","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114857_bib0076","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-931542","article-title":"High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors","volume":"39","author":"Yukimasa","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114857_bib0077","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2005.12.029","article-title":"Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients","volume":"91","author":"Zanardini","year":"2006","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2022.114857_bib0078","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1177\/0300060518817417","article-title":"Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in elderly patients with refractory depression","volume":"47","author":"Zhao","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.psychres.2022.114857_bib0079","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10699","article-title":"Serum BDNF levels and the antidepressant effects of electroconvulsive therapy with ketamine anaesthesia: a preliminary study","volume":"9","author":"Zheng","year":"2021","journal-title":"PeerJ."},{"key":"10.1016\/j.psychres.2022.114857_bib0080","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2147\/NDT.S256278","article-title":"Serum BDNF levels are not associated with the antidepressant effects of nonconvulsive electrotherapy","volume":"16","author":"Zheng","year":"2020","journal-title":"Neuropsychiatr. Dis Treat."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:00:22Z","timestamp":1759039222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":81,"alternative-id":["S0165178122004498"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114857","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114857"}}